FAS and cancer: Repression of SREBP-1c and its targets (ACC, FAS, SCD-1 and GPAT) in the pathway of fatty acid and triglyceride synthesis may indicate an inhibition of de novo lipogenesis in adipose tissue in cancer cachexia.